Quercegen Pharma AG – Trademark Portfolio

Entity Type: 99

Quercegen Pharma AG holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include NUTRISODA, LOVE YOUR BODY, and NUTRI SODA LOVE YOUR BODY. The owner is based in Oberwil Lieli.

Lielistrasse 85

Oberwil Lieli 8966 , CH

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Quercegen Pharma AG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (2 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does Quercegen Pharma AG have?

Quercegen Pharma AG has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Quercegen Pharma AG file in?

Quercegen Pharma AG files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Quercegen Pharma AG's most well-known trademarks?

Quercegen Pharma AG's registered trademark portfolio includes well-known marks such as NUTRISODA, LOVE YOUR BODY, and NUTRI SODA LOVE YOUR BODY. These are among 3 currently registered trademarks in the portfolio.

What is Quercegen Pharma AG's trademark registration success rate?

Quercegen Pharma AG has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.